Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model
Koji Nakamura(Tohoku University), Tatsuaki Morokata(Astellas Pharma (Japan)), Kaori Hanaoka(Astellas Pharma (Japan)), Yuka Kawato(Astellas Pharma (Japan)), Jun Hirose(Kumamoto University Hospital), Takahisa Noto(Astellas Pharma (Japan)), T. Nakanishi, Misato Ito(Fukushima Medical University), Yoko Kaneko(Keio University), Masashi Maeda(Astellas Pharma (Japan)), Hidehiko Fukahori(Astellas Pharma (Japan)), Kaori Kubo(Astellas Pharma (Japan)), Masamichi Inami(Chiba University)
Cited by 4
Related Papers
NAK is an IκB kinase-activating kinase
|Nature|2000|374
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
|Molecular Cancer Research|2016|232
Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
|Journal of Biological Chemistry|1999|100